ArticleslgStudy

science

HIV Haemophilia Litigation

HIV Haemophilia Litigation is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand HIV Haemophilia Litigation rather than just read about it. In short: The HIV Haemophilia Litigation [1990] 41 BMLR 171, [1990] 140 NLJR 1349 (CA), [1989] E N. 2111, also known as AMcG002, and HHL, was a legal claim by 962 plaintiffs, mainly haemophiliacs (but also their wives, partners and children), who were infected with HIV as a result of having been treated with blood products in the late 1970s and early 1980s. The first central defendants were the then Department of Health, with…

HIV Haemophilia Litigation — main illustration
HIV Haemophilia Litigation — illustration

Key takeaways

  • HIV Haemophilia Litigation belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect HIV Haemophilia Litigation to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of HIV Haemophilia Litigation from memory before moving on to harder problems.

Reference excerpt

The HIV Haemophilia Litigation [1990] 41 BMLR 171, [1990] 140 NLJR 1349 (CA), [1989] E N. 2111, also known as AMcG002, and HHL, was a legal claim by 962 plaintiffs, mainly haemophiliacs (but also their wives, partners and children), who were infected with HIV as a result of having been treated with blood products in the late 1970s and early 1980s. The first central defendants were the then Department of Health, with other defendants being the Licensing Authority of the time, (MCA), the CSM (the Committee on the Safety of Medicines), the CBLA (Central Blood Laboratories Authority), and the regional health authorities of England and Wales. In total, there were 220 defendants in the action. The litigation commenced around April 1989 and by 7 July 1989, at least 300 plaintiffs had joined the action. Within four months another 300 haemophiliacs had joined the action, however, by this time, (November 1989) 163 haemophiliacs had already developed full-blown AIDS and 107 had died. There was an initial deadline of 2 February 1990 imposed, but this was extended in order to permit 200 haemophiliac children to sign up to the action.

Principal grounds The plaintiff's principal allegations were that the UK government had been negligent in failing to become sufficient as a country in the supply of blood products at an earlier point, and in delaying the implementation of heat-treatment of clotting factors in order to inactivate HIV. It was further alleged that the defendants did not respond correctly to the AIDS crisis, specifically, in not reacting with urgency to move to banning imported blood products which were derived from paid donors. Another significant ground was breach of duty as provided for in statute, for example, under the National Health Service Act 1977.

Discovery and public interest immunity On 20 September 1990, the Court of Appeal heard an appeal concerning discovery where an order of 31 July 1990 had been made by Mr Justice Rougier that required the first central defendant, the Department of Health, to surrender some, but not all of 600 files of historic papers spanning 1972 to 1986, on which they were asserting public interest immunity (PII). The appeal had been brought by the plaintiffs and was being considered in conjunction with a cross-appeal by the defendants. The documents being withheld under public interest fell into a number of categories: submissions and draft submissions to ministers, policy documents, exchanges with ministers, documents revealing the process by which policy decisions were arrived at, documents showing exchanges between senior officials, briefings to ministers, and position papers on the formulation of future policy prepared by civil servants. Part IV of the Canadian inquiry report by Justice Horace Krever provides a more specific breakdown of the subject matter of the documents which were under consideration during the appeal: documents relating to the drive for self-sufficiency, the allocation of resources, documents on the laboratory (BPL) where blood products were manufactured, on the NBTS, on the screening of donors, on steps to limit the infection with hepatitis, and on heat-treatment of blood products.

The three appellate judges found for the plaintiffs and ordered the PII documents to be disclosed, overturning the ruling of Rougier J of 31 July 1990 and at the same time, the cross-appeal by the Department of Health was dismissed. Lord Justice Bingham recorded in the judgment that he felt "the tragedy was avoidable in the sense that, had different measures been taken in the 1970s and early 1980s, it could, at least in large measure, have been prevented."

Out-of-court settlement On 26 June 1990, Mr Justice Ognall took the rare initiative of issuing a handwritten note imploring the parties to give anxious consideration to settling the action out of court. He stressed the moral obligation and duty that fell on the UK government toward the HIV-infected haemophiliacs. However, the judge's plea was resisted for several months by the Health Secretary, Mr Kenneth Clarke, and was still being rebutted on 16 October 1990. The Chief Medical Officer, Donald Acheson, was also keen for the government to settle the action. The haemophiliac plaintiffs were developing AIDS and 130 infected haemophiliacs had already died by 9 November 1990. The next month, the action was settled out-of-court by which time the number of plaintiffs on the roll of names had risen to 1,217. It was reported on 4 February 2022 in the i newspaper that a Department of Health memo, unearthed at the National Archives, revealed that senior government officials held the belief in 1995 that the government would have been found negligent and lost the HIV Haemophilia Litigation had the case gone to full trial.

… excerpt ends here. Continue reading the full article.

Illustrations

HIV Haemophilia Litigation illustration

Worked examples

Example 1 — a first encounter with HIV Haemophilia Litigation

Start with the simplest possible case. Write down what HIV Haemophilia Litigation claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to HIV Haemophilia Litigation before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about HIV Haemophilia Litigation ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of HIV Haemophilia Litigation

In research
HIV Haemophilia Litigation appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses HIV Haemophilia Litigation in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
HIV Haemophilia Litigation is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1990 in United Kingdom case law, Contaminated blood case law, Contaminated haemophilia blood products, so understanding it makes those chapters shorter.
In everyday life
Look for HIV Haemophilia Litigation outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “HIV Haemophilia Litigation” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study HIV Haemophilia Litigation in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what HIV Haemophilia Litigation means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain HIV Haemophilia Litigation out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is HIV Haemophilia Litigation in simple terms?

The HIV Haemophilia Litigation [1990] 41 BMLR 171, [1990] 140 NLJR 1349 (CA), [1989] E N. 2111, also known as AMcG002, and HHL, was a legal claim by 962 plaintiffs, mainly haemophiliacs (but also their wives, partners and children), who were infected with HIV as a result of having been treated with…

Why does HIV Haemophilia Litigation matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study HIV Haemophilia Litigation?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on HIV Haemophilia Litigation.

Tags

  • 1990 in United Kingdom case law
  • Contaminated blood case law
  • Contaminated haemophilia blood products
  • HIV/AIDS

Keep exploring